Revvity RVTY Life Sciences — Segment revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Revvity in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Revvity's life sciences — segment revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Revvity's life sciences — segment revenue?
- Revvity (RVTY) reported life sciences — segment revenue of $361.85M in Q1 2026.
- How has Revvity's life sciences — segment revenue changed year-over-year?
- Revvity's life sciences — segment revenue increased by 6.3% year-over-year, from $340.4M to $361.85M.
- What is the long-term trend for Revvity's life sciences — segment revenue?
- Over 3 years (2022 to 2025), Revvity's life sciences — segment revenue has grown at a 3.4% compound annual growth rate (CAGR), from $1.29B to $1.43B.
- What does life sciences — segment revenue mean?
- Total sales generated by the Life Sciences business unit.
- How do you interpret life sciences — segment revenue?
- An increase indicates growing market share or successful product adoption, while a decrease suggests competitive pressure or reduced demand.
- How does life sciences — segment revenue compare across companies?
- Commonly reported as Segment Revenue or Net Sales in peer life science and diagnostics companies.